TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01785355 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00096993 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02164032 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02113670 — Predictive Biomarker (PRD): ALPP mRNA
Genes: ALPP; PLAP
Study NCT02400255 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT00599417 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT00599417 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02574260 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02856763 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00047346 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00006511 — Predictive Biomarker (PRD): Chromosome 5q
Study NCT04697329 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00666926 — Predictive Biomarker (PRD): PTK2 mRNA
Genes: PTK2; FAK; FAK1
Study NCT00666926 — Predictive Biomarker (PRD): PTK2B mRNA
Genes: PTK2B; FAK2; PYK2; RAFTK
Study NCT03644459 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03644459 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT00386100 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03156582 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT01416298 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01416298 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02600780 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT04491071 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05427617 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03367273 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study NCT01626937 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03396952 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT00597597 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00597597 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04109066 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04109066 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04109066 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00481845 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00481845 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00669136 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT00669136 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00004029 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT03399201 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01303055 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT05800301 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00697957 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01234155 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT04476602 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01064375 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT01064375 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05257512 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04620330 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT04620330 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02935283 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study NCT02365233 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04894864 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04894864 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03618056 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03618290 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01146431 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04007588 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT01083667 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT03225040 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02878161 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03810872 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03810872 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03810872 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT02499445 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT01172015 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study NCT00148694 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03255083 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02997969 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02549716 — Safety Biomarker (SAF): Interleukin 1
Study NCT02549716 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01275703 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05616429 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05708807 — Pharmacodynamic Biomarker (PDY): Platelet-derived growth factor B
Genes: PDGFB; PDGF2; SIS
Study NCT03390985 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT04291196 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01838525 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01838525 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT01838525 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00850005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04520789 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT04520789 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT03637088 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04183361 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study NCT01259700 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00693082 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01629615 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00465400 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00815789 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00815789 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01935323 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03347292 — Predictive Biomarker (PRD): TP53INP2 mRNA
Genes: TP53INP2; C20orf110; DOR; PINH
Study NCT03543787 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03118661 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT01469975 — Predictive Biomarker (PRD): FZD10 mRNA
Genes: FZD10
Study NCT01291017 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study NCT05539846 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01448603 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT04321135 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT02914808 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT02922257 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): FKBP5 mRNA
Genes: FKBP5; AIG6; FKBP51
Study NCT02922257 — Predictive Biomarker (PRD): SGK1 mRNA
Genes: SGK1; SGK
Study NCT00792571 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01803776 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03975244 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05048511 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT04768023 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04337515 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02700074 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03299894 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00444678 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02222480 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03595267 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03663400 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study NCT03429478 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04391400 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02855541 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01413074 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01413074 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04263584 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study NCT04650451 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01288560 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01288560 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study NCT00693199 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02863211 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03265054 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT02532699 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04204551 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04204551 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT04204551 — Safety Biomarker (SAF): BDNF
Study NCT01257464 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00236275 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT03515837 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03515837 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01185730 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01996657 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT03287518 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03287518 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03007134 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00294762 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00294762 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03569202 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01541397 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01029860 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02222714 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT06110221 — Safety Biomarker (SAF): Interleukin 1
Study NCT03462511 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03961698 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00929955 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01484782 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00190255 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT02956005 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT01566799 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02981797 — Pharmacodynamic Biomarker (PDY): Gamma-Histone H2AX
Genes: H2AX; H2AFX
Study NCT01163786 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study NCT02805205 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04137783 — Predictive Biomarker (PRD): ABCA3 mRNA
Genes: ABCA3; ABC3
Study NCT00132730 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02709681 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03157310 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03157310 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00356512 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT02166944 — Predictive Biomarker (PRD): TARDBP mRNA
Genes: TARDBP; TDP43
Study NCT00357760 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01490801 — Predictive Biomarker (PRD): ITK mRNA
Genes: ITK; EMT; LYK
Study NCT00140894 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT03986255 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02767583 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00944034 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study NCT02876692 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02876692 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02250209 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00089115 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02538484 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02538484 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT03416283 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00113282 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00113282 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03585855 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04093648 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT04093648 — Predictive Biomarker (PRD): IL21
Genes: Za11; IL-21
Study NCT02278978 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT04279899 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02987777 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02987777 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT00264914 — Surrogate Endpoint (SUR): Serum sodium
Study NCT04456829 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02301039 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02894229 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03368547 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02779660 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study NCT00552747 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT00639080 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00141973 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03983551 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02527772 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT03894007 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03894007 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00922727 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01858129 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study NCT00047645 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01461148 — Predictive Biomarker (PRD): AIM2 mRNA
Genes: AIM2
Study NCT01461148 — Predictive Biomarker (PRD): TAF1B mRNA
Genes: TAF1B
Study NCT02557061 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02557061 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02557061 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study NCT02557061 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study NCT02557061 — Predictive Biomarker (PRD): CD24 mRNA
Genes: CD24; CD24A
Study NCT02557061 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT02557061 — Predictive Biomarker (PRD): CCR7 mRNA
Genes: CCR7; CMKBR7; EBI1; EVI1
Study NCT02557061 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study NCT00481871 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00769015 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03377387 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00975897 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00199732 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02916537 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00003490 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02349009 — Predictive Biomarker (PRD): THBS1 mRNA
Genes: THBS1; TSP; TSP1
Study NCT02349009 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study NCT04633447 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT03384420 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT02135380 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01241812 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study NCT00814814 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT03137615 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00660686 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03449524 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03449524 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT00350337 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01862120 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03597022 — Predictive Biomarker (PRD): TFPI mRNA
Genes: TFPI; LACI; TFPI1
Study NCT03288233 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT02916602 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04325841 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00314002 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT04479904 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT03326960 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00978757 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02073916 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04502303 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT01142804 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02277639 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00831922 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04316949 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01846052 — Predictive Biomarker (PRD): CNGB3 mRNA
Genes: CNGB3
Study NCT00001300 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03229694 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03229694 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT04456985 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03456882 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT02133703 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03004807 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02445833 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05535179 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05535179 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03471624 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01306929 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT03045029 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00788684 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00464451 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01347216 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01547767 — Predictive Biomarker (PRD): ISCU mRNA
Genes: ISCU; NIFUN
Study NCT02457104 — Predictive Biomarker (PRD): FFAR2 mRNA
Genes: FFAR2; FFA2; GPCR43; GPR43
Study NCT04524585 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT04523532 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study NCT04523532 — Predictive Biomarker (PRD): POMC mRNA
Genes: POMC
Study NCT02786823 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03594240 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT01928966 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03744806 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00412438 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study NCT02078219 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT01395524 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT04623697 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1